Want to see JP:4889 full AI Analyst Report?
Renascience Inc. (4889) Stock Statistics & Valuation Metrics
Total Valuation
Renascience Inc. has a market cap or net worth of JPY 13.38B. The enterprise value is JPY 18.26B.
- Market Cap
- JPY 13.38B
- Enterprise Value
- JPY 18.26B
Share Statistics
Renascience Inc. has 13,776,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,776,900
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Renascience Inc.’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -10.74%.
- Return on Equity (ROE)
- -0.09
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -10.74%
- Return on Capital Employed (ROCE)
- -0.11
- Revenue Per Employee
- 22.85M
- Profits Per Employee
- -100.43M
- Employee Count
- 3
- Asset Turnover
- 0.02
- Inventory Turnover
- 362.17
Valuation Ratios
The current PE Ratio of Renascience Inc. is -40.32. Renascience Inc.’s PEG ratio is 0.09.
- PE Ratio
- -40.32
- PS Ratio
- 195.14
- PB Ratio
- 4.13
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.09
Income Statement
In the last 12 months, Renascience Inc. had revenue of 68.55M and earned -301.28M in profits. Earnings per share was -23.39.
- Revenue
- 68.55M
- Gross Profit
- 64.21M
- Operating Income
- -356.88M
- Pretax Income
- -300.27M
- Net Income
- -301.28M
- EBITDA
- -356.88M
- Earnings Per Share (EPS)
- -23.39
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Renascience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -2.37%
Stock Price Statistics
- Beta
- 0.82
- 52-Week Price Change
- -47.14%
- 50-Day Moving Average
- 1130.62
- 200-Day Moving Average
- 1451.59
- Relative Strength Index (RSI)
- 34.62
- Average Volume (3m)
- 313.14K
Important Dates
Renascience Inc. upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- Nov 11, 2026
- Ex-Dividend Date
- ―
Financial Position
Renascience Inc. as a current ratio of 19.40, with Debt / Equity ratio of 0.00%
- Current Ratio
- 19.40
- Quick Ratio
- 19.40
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 9.53
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Renascience Inc. has paid 1.00M in taxes.
- Income Tax
- 1.00M
- Effective Tax Rate
- -0.00
Enterprise Valuation
Renascience Inc. EV to EBITDA ratio is -30.36, with an EV/FCF ratio of 0.00.
- EV to Sales
- 148.39
- EV to EBITDA
- -30.36
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Renascience Inc. has JPY 3.20B in cash and marketable securities with JPY 0.00 in debt, giving a net cash position of JPY 3.20B billion.
- Cash & Marketable Securities
- JPY 3.20B
- Total Debt
- JPY 0.00
- Net Cash
- JPY 3.20B
- Net Cash Per Share
- JPY 232.60
- Tangible Book Value Per Share
- JPY 235.22
Margins
Gross margin is 93.66%, with operating margin of -491.15%, and net profit margin of -461.59%.
- Gross Margin
- 93.66%
- Operating Margin
- -491.15%
- Pretax Margin
- -460.13%
- Net Profit Margin
- -461.59%
- EBITDA Margin
- -488.85%
- EBIT Margin
- -488.87%
Analyst Forecast
The average price target for Renascience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -33.24%
- EPS Growth Forecast
- -581.78%
Scores
- Smart Score
- ―
- AI Score
- 41
